(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol

(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name (3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol
Generic (3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol
Type
Formula C15H28N2O5
Weight Average: 316.3932
Monoisotopic: 316.199822016
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol
(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol

Innovators Monograph

You find simplified version here (3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=46937066
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443838
https://www.chemspider.com/Chemical-Structure.25057981.html
https://zinc.docking.org/substances/ZINC000038377610
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AM3
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE
N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide
(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol
3-(10-methyl-9-anthryl)propanoic acid
Anisomycin
5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)
N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE
4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol
1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)
Salicylates Level
Histocompatibility antigen test
Mental Health Screening
Glucose tolerance test - non-pregnant
Streptococcal screen
Natriuretic Peptide Tests (BNP, NT-proBNP)
Fecal smear
Extremity angiography
Heart CT scan
Synovial fluid analysis
Secondary Bacterial Infection
Urinary tract infection caused by E. coli
Recurrent Ventricular fibrillation
severe Pain
Degenerative Brain Disorder
Respiratory Symptoms caused by Cystic fibrosis
Neuromuscular blockade caused by vecuronium bromide
Upper Respiratory Tract Infection
Primary Progressive
Respiratory Tract Infections (RTI)